To include your compound in the COVID-19 Resource Center, submit it here.

Cypher sirolimus-eluting stent: Pivotal; marketed in Europe

Preliminary data from a bifurcation feasibility study in 86 patients showed that the Cypher stent gave a >60% improvement

Read the full 198 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE